Ooni Koda
  1. Home
  2. /
  3. Newsfeed
  4. /
  5. Survey: Only 17% accessibility rate for Romanians to...

Survey: Only 17% accessibility rate for Romanians to new medicines approved at European level in 2019-2022

July 18, 2024

  Romanians have access to only 17% of the medicines approved at European level in the period 2019-2022, in 2023, no new medicines were unconditionally subsidised in our country, and in 2024 only 28 new medicines were included in the list of those subsidised, according to data from the study of the European Federation of Pharmaceutical Industries and Associations (EFPIA) on the Indicator of Access to Innovative Medicines Patients W.A.I.T. (Waiting to Access Innovative Therapies) for 2023.The Romanian Association of International Manufacturers of Medicines (ARPIM) made public on Thursday a series of data from three reports published in June 2024 by EFPIA, data collected from 36 countries (27 from the EU and 9 from outside the EU) that provide information on the 167 innovative medicines with centralized marketing authorization in the period 2019-2022.Dr. Ioana Bianchi, Director of Foreign Affairs at ARPIM, said that, according to the study data, in Romania, the availability rate of oncological drugs was 19% (out of the 48 that received European approval between 2019 and 2022, only 9 were available in Romania on January 5, 2024) as well as in the case of "orphan" drugs (drugs dedicated to the treatment of rare diseases) which was also 19%.Out of 167 innovative medicines that received approval from the European Medicines Agency (EMA) between 2019 and 2022, only 29 medicines were available in Romania on 5 January 2024. No medicine approved at European level in 2022 was subsidised in Romania on January 5, 2024.The drop is dramatic compared to last year's similar study, which showed an availability rate of 30% (51 drugs), the study data also highlights.As for the access time, i.e. the time from approval by the European Medicines Agency (EMA) to availability in Romania, it is 778 days, while German patients, for instance, have access to state-of-the-art medicines in just 126 days, according to the data presented by Dr. Bianchi.In our country, the main reasons why pharmaceutical companies have to wait to submit their evaluation files are: the evaluation criteria, the technical and human infrastructure necessary for diagnosing diseases, so the average time for submitting files is 86 days, but the average time for a reimbursement decision is 563 days, the data of the said study reads.  

Read in full - click here
Romanian president Nicușor Dan courts Austrian business sector at Salzburg Industrialists' Summit

President Nicușor Dan, in office for roughly three months, attended the Salzburg Industrialists' Summit, the most important reunion of the Austrian business community, urging them to invest in Romania. Specifically, the president emphasized the strategic opportunities in the defense, energy, infrastructure, and logistics sectors. “Romania is significantly expanding its defense industry. Our sector offers real […]

Romanian deputy prime minister embroiled in controversy after one of his companies paid bribes to ANAF inspector

A scandal broke out on Friday, July 25, after it was made public that deputy prime minister Dragoș Anastasiu was a witness in an older corruption case involving one of his companies. The company, Eurolines, paid bribes for eight years to a financial inspector from Romania’s tax agency ANAF.  Records from the Anti-Corruption Directorate show that between […]

Romanian deputy prime minister embroiled in controversy after one of his companies paid 'protection tax' to ANAF inspector

A scandal broke out on Friday, July 25, after it was made public that deputy prime minister Dragoș Anastasiu was a witness in an older corruption case involving one of his companies. The company, Eurolines, paid bribes for eight years to a financial inspector from Romania’s tax agency ANAF.  Records from the Anti-Corruption Directorate show that between […]

Central Romania: Drapers’ Bastion in Brașov to be restored with EU funding

The Drapers' Bastion in Brașov, built between the years 1450–1455, will be restored with European funds. The urban landmark will become an interactive museum integrated into the tourist circuit. The rehabilitation of the Drapers' Tower will support not only tourism but also the construction sector, contributing to the economic and cultural revitalization of Brașov, according […]

Bucharest braces for sweltering weekend as code-red heat alert issued for southern Romania

The National Meteorological Administration (ANM) has issued a code-red warning for persistent and intense heat from July 26, 10:00 AM to July 27, 10:00 AM for the regions of Banat, Oltenia, most of Muntenia, and southern continental Dobrogea. Day temperatures are expected to reach between 39 and 43 degrees Celsius, while the temperature-humidity index is […]

Jazz Bastion: Brașov landmark to host jazz concerts next month

The fifth edition of Jazz Bastion will bring three concerts to the Weavers' Bastion in Brașov, featuring musicians from Romania, Ireland, and Switzerland. This year's edition "highlights the cultural diversity of music, which always brings together artists and audiences alike, regardless of language, nationality or affinities," the organizers explained. The public can attend performances by […]